News from the BioRegion STERN

Here you'll find all press releases and news from companies and institutes in the STERN BioRegion.

04/02/2020 | CureVac AG

Jean Stéphenne Elected as New Chairman of the Supervisory Board of CureVac

CureVac AG, a clinical stage biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that Jean Stéphenne, former deputy Chairman of the Supervisory Board, has been appointed as the new Chairman with immediate effect. Jean Stéphenne has been a member of the Board since September 2015.
04/01/2020 | Curetis GmbH

Curetis and OpGen Close Business Combination

Following approval of shareholders, companies sign German transfer agreement Curetis GmbH and its subsidiaries Curetis USA Inc.and Ares Genetics GmbH are now wholly owned by OpGen, Inc. OpGen consideration shares to be distributed to Curetis N.V. shareholders and Curetis N.V. to be dissolved and delisted from Euronex Three Curetis N.V. Sup...
Synovo GmbH
03/30/2020

Availability of SARS-CoV-2 assays and Covid-19 immunity profiling.

Synovo GmbH has implemented the CDC assay for the detection of SARS-CoV-2 – the agent causing the Covid-19 outbreak.
03/30/2020 | DIN e. V.

COVID-19: DIN makes standards for medical equipment available

Members of the European standards organizations CEN and CENELEC support the fight against coronavirus
03/30/2020 | Ovesco Endoscopy AG

EMR+ enables a grasp-and-snare technique and consequently facilitates en-bloc resection of larger lesions compared to conventional EMR

In lesions > 2 cm, EMR+ outdoes its advantages: comparative trial demonstrates en-bloc resection rate of 86.36 % in 3 cm lesions with EMR+ vs. 18.18 % with conventional EMR
03/29/2020 | European Union, European Cluster Collaboration Platform (ECCP)

European Commission: European standards for medical supplies made freely available to facilitate increase of production

In the context of the Coronavirus crisis, the Commission is working with industry and Member States to maximise the availability of masks, gloves, gowns and other medical supplies. Efforts include increasing production by existing manufacturers, facilitating imports and activating alternative ways of producing equipment.
03/28/2020 | European Commission

Statement from Commission President von der Leyen on proposals to fight the economic effects of the coronavirus crisis

The European Council tasked the Eurogroup to come up with proposals within the next weeks. The Commission will participate in these discussions and stands ready to assist, if supported by the Eurogroup. This is required since the fiscal space for new instruments is limited as we are in the last year of the MFF.
03/26/2020 | Insilico Biotechnology AG

Insilico Biotechnology AG incorporates Singapore subsidiary

Stuttgart - Insilico Biotechnology AG has announced the foundation of its Singapore subsidiary, Insilico Biotechnology Pte. Ltd. This step enables the newly formed company to efficiently serve Insilico’s customers within Singapore and the APAC region. Insilico Biotechnology Pte. Ltd. will catalyze the digital transformation of the biopharmaceutical...
03/26/2020 | Bosch Healthcare Solutions GmbH

Bosch developing COVID-19-(SARS-CoV-2) rapid testing kit for the Vivalytic platform

Test delivers reliable results at the point of care in less than 2.5 hours „One of the world’s first multiplex molecular diagnostic tests that can identify COVID-19 and distinguish it from nine other respiratory infections with similar symptoms, like influenza „The test meets the requirements of the World Health Organization (WHO) and was d...
03/26/2020 | MAHLE GmbH

MAHLE and Triumph cooperate in the manufacture of face masks

MAHLE and the underwear manufacturer Triumph Holding AG (Bad Zurzach – “Triumph”) are joining forces to manufacture face masks. MAHLE is providing a filter medium that is FFP3 rated and absorbs viruses. Production of the respiratory masks at Triumph is starting immediately. The masks, that can also be used in the medical sector, will be supplied to...
03/25/2020 | NMI Naturwissenschaftliches und Medizinisches Institut

The NMI in Reutlingen is investigating the immunological response triggered by the coronavirus

The NMI Natural and Medical Sciences Institute at the University of Tübingen is focusing its research efforts into infections with the novel coronavirus (SARS-CoV-2). The NMI is investigating COVID-19 immunity and has also joined an international consortium working towards developing neutralising antibodies for the virus. This urgent corona researc...
03/24/2020 | Synovo GmbH

Synovo announces entry into development of its Covid-19 viral pneumonia therapy candidate.

Synovo GmbH announced that it will accelerate development of SYD015, a compound designed to treat acute viral and bacterial pneumonia and acute respiratory distress syndrome (ARDS).  Although generally active in pneumonia, the compounds have properties that make them particularly relevant to use for acute Covid-19 pneumonia and respiratory dis...
03/18/2020 | European Union, European Cluster Collaboration Platform (ECCP)

European industrial clusters coordinate their resources to fight COVID-19

Brussels, 18 March 2020. In light of the coronavirus crisis, Europe is mobilising all its powers to coordinate the national responses to fight COVID-19, to reinforce the public health sectors of the Member States and to support the economy.
03/17/2020

T4M – Technology for Medical Devices postponed to May 2021

Medical Technology Expo to take place in Stuttgart from 4–6 May 2021 / Around 95 percent of exhibitors have confirmed that they will attend next year
03/17/2020 | immatics biotechnologies GmbH

Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies

Upon successful completion of the business combination, Immatics will receive up to approximately $148 million of cash held within Arya’s trust account Leading institutional investors commit $104 million of cash through a common stock private investment in public equity (“PIPE”) led by Perceptive Advisors and other top-tier US healthcare inves...
03/17/2020 | immatics biotechnologies GmbH

Immatics Announces Business Combination with Arya Sciences Acquisition Corp., Creating a Publicly Listed Leader in TCR-based Immunotherapies

Upon successful completion of the business combination, Immatics will receive up to approximately $148 million of cash held within Arya’s trust account Leading institutional investors commit $104 million of cash through a common stock private investment in public equity (“PIPE”) led by Perceptive Advisors and other top-tier US healthcare inves...
03/16/2020 | Curetis GmbH

Curetis Begins Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe

Rapid real-time PCR test allows testing for SARS-CoV2 in only a few hours Test kit to be made available via Curetis’ European sales channels Synergies with Curetis Unyvero HPN panel for pneumonia testing for bacterial co-infections in Covid-19 patients  
03/15/2020 | CureVac AG

CureVac focuses on the development of mRNA-based coronavirus vaccine to protect people worldwide

The company rejects current rumors of an acquisition
03/11/2020 | bioMérieux Deutschland GmbH

First of 3 diagnostic tests for SARS-CoV-2 coronavirus available from bioMérieux

bioMérieux, a world leader in the field of in vitro diagnostics, is announcing the forthcoming launch of 3 different tests to address the COVID-19 epidemic and to meet the different needs of physicians and health authorities in the fight against this emerging infectious disease.
03/11/2020 | CureVac AG

Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG

TÜBINGEN, Germany/ BOSTON – March 11, 2020 – CureVac AG, a clinical stage biopharmaceutical company pioneering the field of mRNA-based drugs, today announced that company founder and Chairman of the Supervisory Board Ingmar Hoerr is replacing Daniel Menichella in his function as Chief Executive Officer (CEO).